AD-1232

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-1232, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232 [Phase 1]

See pricing